Novo Nordisk opens new insulin factory in Russia
COPENHAGEN, April 10 (Reuters) - Denmark's Novo Nordisk said on Friday it had opened a factory in Kaluga, Russia, for the production and assembly of insulin cartridges and pre-filled injection pens used for the treatment of diabetes.
The world's biggest insulin producer, Novo Nordisk also has production sites in Denmark, Brazil, China, France and the United States. (Reporting by Teis Jensen; editing by Jason Neely)
© Thomson Reuters 2017 All rights reserved.